Stoltz JA, Wood E, Miller C, Small W, Li K, Tyndall M, Montaner J, Kerr T Characteristics of young illicit drug injectors who use North America's first medically supervised safer injecting facility Addiction Research & Theory, 2007. Taylor & Francis Online
Wood E, Hogg RS, Kerr T, Bonner S, Strathdee SA, Palepu A, Montaner JS Rates of inappropriate antiretroviral prescription among injection drug users Harm Reduction Journal, 2007. PubMed
Small W, Rhodes T, Wood E, Kerr T Public injection settings in Vancouver: physical environment, social context and risk International Journal of Drug Policy, 2007. PubMed
McKnight I, Maas B, Wood E, Tyndall MW, Small W, Lai C, Montaner JS, Kerr T Factors associated with public injecting among users of Vancouver's supervised injection facility American Journal of Drug and Alcohol Abuse, 2007. PubMed
Kerr T, Kimber J, Rhodes T Drug use settings: an emerging focus for research and intervention International Journal of Drug Policy, 2007. PubMed
Miller CL, Strathdee SA, Li K, Kerr T, Wood E A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IDUs) American Journal of Drug and Alcohol Abuse, 2007. PubMed
Tyndall MW, Wood E, Zhang R, Lai C, Montaner JSG, Kerr T HIV seroprevalence among participants at a Supervised Injection Facility in Vancouver, Canada: implications for prevention, care and treatment Harm Reduction Journal, 2006. PubMed
DeBeck K, Wood E, Montaner J, Kerr T Canada's 2003 renewed drug strategy - an evidence-based review HIV/AIDS Policy & Law Review, 2006. PubMed
Wood E, Tyndall MW, Montaner JS, Kerr T Summary of findings from the evaluation of a pilot medically supervised safer injecting facility Canadian Medical Association Journal, 2006. PubMed
Braitstein P, Li K, Kerr T, Montaner JS, Hogg RS, Wood E Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone AIDS Care, 2006. PubMed
